324 related articles for article (PubMed ID: 29730062)
1. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
[TBL] [Abstract][Full Text] [Related]
3. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
4. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
[TBL] [Abstract][Full Text] [Related]
5. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
6. Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer.
Hsieh CH; Shueng PW; Wang LY; Huang YC; Liao LJ; Lo WC; Lin YC; Wu LJ; Tien HJ
BMC Cancer; 2016 Feb; 16():139. PubMed ID: 26906330
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes.
Ahmed F; Sarkar V; Gaffney DK; Salter B; Poppe MM
Med Dosim; 2016; 41(3):195-8. PubMed ID: 26994828
[TBL] [Abstract][Full Text] [Related]
8. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
11. Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
Razavian NB; D'Agostino RB; Shenker RF; Hughes RT
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):652-663. PubMed ID: 37150263
[TBL] [Abstract][Full Text] [Related]
12. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer.
Nguyen NP; Ceizyk M; Vos P; Vinh-Hung V; Davis R; Desai A; Abraham D; Krafft SP; Jang S; Watchman CJ; Ewell L; Hamilton R; Smith-Raymond L
Oral Oncol; 2010 Apr; 46(4):283-6. PubMed ID: 20188620
[TBL] [Abstract][Full Text] [Related]
14. IMRT for image-guided single vocal cord irradiation.
Osman SO; Astreinidou E; de Boer HC; Keskin-Cambay F; Breedveld S; Voet P; Al-Mamgani A; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):989-97. PubMed ID: 21300449
[TBL] [Abstract][Full Text] [Related]
15. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
16. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
17. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.
Fondevilla Soler A; López-Guerra JL; García Fernández A; Samaniego Conde MA; Belmonte González MJ; Praena-Fernandez JM; Rivin Del Campo E; Alcaraz M; Azinovic I
Clin Transl Oncol; 2019 Jul; 21(7):881-890. PubMed ID: 30506131
[TBL] [Abstract][Full Text] [Related]
18. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
